おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Perrigo
company
About
Providing the world with quality, affordable healthcare products.
- 10001 - max
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $2.60B
- Industries
- Biotechnology,Manufacturing,Pharmaceutical
- Founded date
- Jan 1, 1887
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.60B
Perrigo has raised a total of
$2.60B
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2022 | Post-IPO Debt | $2.60B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Perrigo is funded by 1 investors.
JP Morgan Chase
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
JP Morgan Chase
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
